Diabetes Clinical Trials in Indiana

40 recruiting studies across 1 city

Browse by City

All Trials in Indiana

Phase

Trial	Phase	Sponsor	Dist.
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma	Phase 2	Children's Oncology Group	<1 mi
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes	Phase 2	SAb Biotherapeutics, Inc.	<1 mi
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)	Phase 1/2	COUR Pharmaceutical Development Company, Inc.	<1 mi
TrialNet Pathway to Prevention of T1D	—	University of South Florida	<1 mi
Biomarker of Diabetic Retinopathy	—	Indiana University	<1 mi
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes	Phase 2	Zucara Therapeutics Inc.	<1 mi
The Gut Microbiome in Type 1 Diabetes and Mechanism of Metformin Action	Phase 2	Heba M. Ismail	<1 mi
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events	N/A	Cleerly, Inc.	<1 mi
Monitoring Exhaled Breath to Noninvasively Detect Glycemic Events	N/A	Indiana University	<1 mi
Diabetes RElated to Acute Pancreatitis and Its Mechanisms	—	Milton S. Hershey Medical Center	<1 mi
Bionic Pancreas in CFRD	Phase 3	Jaeb Center for Health Research	<1 mi
Drug Interaction Potential of Pro-Inflammatory Conditions	—	Indiana University	<1 mi
INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes	Phase 2	Mannkind Corporation	<1 mi
Diabetes RElated to Acute Pancreatitis and Its Mechanisms: Metabolic Outcomes Using Novel CGM Metrics	—	Milton S. Hershey Medical Center	<1 mi
Enhancing Shared Decision-making to Guide Care for People With Dementia and Diabetes	N/A	Indiana University	<1 mi
Registry for Stage 2 Type 1 Diabetes	—	Sanofi	<1 mi
Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease	Phase 2	Pharming Technologies B.V.	<1 mi
Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes	N/A	Indiana University	<1 mi
CAMP RWE Trial: Amnion Grafts for Healing Hard-to-Heal Ulcers in RW Populations	N/A	Capsicure, LLC	<1 mi
Rare and Atypical Diabetes Network	—	University of South Florida	<1 mi
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)	Phase 3	Eli Lilly and Company	<1 mi
Type 1 Diabetes Extension Study	—	National Institute of Allergy and Infectious Diseases (NIAID)	<1 mi
Denosumab for Type 1 Diabetes	Phase 1/2	City of Hope Medical Center	<1 mi
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes	Phase 3	Eli Lilly and Company	<1 mi
To Study the Efficacy and Safety of Medtronic 780G Insulin Pump in People With Gastroparesis and Type 1 Diabetes.	N/A	Viral N. Shah	<1 mi
A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes	Phase 1/2	City of Hope Medical Center	<1 mi
Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus	Phase 2	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	<1 mi
The Effects of Cognitive Behavioral Therapy on Insulin Resistance in People With HIV	N/A	Indiana University	<1 mi
Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System	N/A	Insulet Corporation	<1 mi
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM	Phase 3	AstraZeneca	<1 mi
A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes	Phase 2	Novo Nordisk A/S	<1 mi
CAMPR-II RWE TRIAL: A Saline-hydrated Allogeneic Dual-layer Amniotic Membrane Product or a Synthetic, Resorbable Polymeric Wound Matrix to a Coarsened Exact Matched Retrospective Control Cohort of Hard to Heal DFUs and VLUs	N/A	Capsicure, LLC	<1 mi
Miniaturized Breath-based Sensor for the Detection of Hypo- and Hyperglycemia	N/A	Indiana University	<1 mi
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes	Phase 3	Novo Nordisk A/S	<1 mi
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes	Phase 3	Ascletis Pharma (China) Co., Limited	<1 mi
App-Based Certified Diabetes Education Therapy (AB-CDE)	N/A	Oregon Health and Science University	<1 mi
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease	Phase 3	Boehringer Ingelheim	13 mi
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide	Phase 2	Eli Lilly and Company	14 mi
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications	Phase 3	Novo Nordisk A/S	21 mi
Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes	N/A	Insulet Corporation	46 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.